Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
NCT06681428
This study is recruiting at 9 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Diabetic Foot Ulcer (DFU)
- Chronic Foot Ulcers
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Tides Medical
- Last updated on ClinicalTrials.gov
- February 10, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 4
- Limb Preservation Platform Inc · Fresno, CA
- Angel City Research · Los Angeles, CA
- Clemente Clinical Research · Los Angeles, CA
- ILD Research Center · Vista, CA
Florida · 1
- Clever Medical Research · Miami, FL
North Carolina · 1
- Foot and Ankle Specialists of the Mid-Atlantic · Raleigh, NC
Ohio · 2
- Lower Extremity Institute of Research and Therapy · Boardman, OH
- Brock Liden DPM · Circleville, OH
Virginia · 1
- Foot and Ankle Specialists of the Mid-Atlantic · Salem, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.